Popular searches: AAPL TSLA NVDA MSFT GOOGL

BBIO Stock Price Prediction 2026

BridgeBio Pharma, Inc. Common Stock

$77.27
$-1.83 (-2.31%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • TTM Squeeze ON for 20 days - volatility compression
  • • Price consolidating in 4.68% range for 15 days
  • • Volume showing accumulation (CMF: 0.1334)
MACD: Bearish | Volume: Accumulation
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.133
Money Flow Index (MFI): 43.3

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Options Analysis: 1-Year Target Strategy

Score: 9/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG SELL SIGNAL - Massively overpriced, excellent premium selling opportunity
Wall Street Target
$93.15
+20.6% upside
Best Strike Found
$100.00
Exp: Jan. 15, 2027, midnight
Call Premium
$9.50
12.3% of stock price
Breakeven Price
$109.50
⚠ Above target
Implied Probability
43.5%
Market's confidence
Value Score
-100.0
Overpriced
💰
STRONG SELL
Options are overpriced - Sell premium opportunity
Seller's Advantage:
Premium Collected
$9.50
Profit if Target Hits
$9.50
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for 20.6% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 71 | Volume: 1
Data as of: Jan 30, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $78.54 +1.6%
90 Days $81.24 +5.1%
6 Months $85.21 +10.3%
1 Year $93.15 +20.6%

More BBIO Analysis

Why is BBIO Moving? Buy or Sell BBIO? BBIO Full Analysis BBIO Trendline Analysis
BBIO Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$116.44 (+50.7%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$93.15 (+20.6%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$65.20 (-15.6%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
54.6
Neutral
MACD Signal
Bearish
Trend
Uptrend
Money Flow (CMF)
0.13

Key Fundamentals

P/S Ratio (TTM)
41.97x
High Premium
Revenue Growth (QoQ)
43.2%
Market Cap
$14,849M
Analyst Target
$93.15
52-Week High
$77.73
52-Week Low
$77.23
Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis